This is a preview of subscription content, log in via an institution to check access.
REFERENCES
P. Klippert, P. Borm, and J. Noordhoek. Prediction of intestinal first-pass effect of phenacetin in the rat from enzyme kinetic data—Correlation with in vivo data using mucosal blood flow. Biochem. Pharmacol. 31:2545-2548 (1982).
S. K. Gupta, A. Bakran, R. W. Johnson, and M. Rowland. Erythromycin enhances the absorption of cyclosporine. Br. J. Clin. Pharmacol. 25:401-402 (1988).
J. C. Kolars, P. L. Stetson, B. D. Rush, M. J. Ruwart, P. Schmiedlin-Ren, E. A. Duell, J. J. Voorhees, and P. B. Watkins. Cyclosporine metabolism by P450IIIA in rat enterocytes—Another determinant of oral bioavailability? Transplantation 53:596-602 (1992).
M. F. Hebert, J. P. Roberts, T. Prueksaritanont, and L. Z. Benet. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin. Pharmacol. Ther. 52:453-457 (1992).
D. Y. Gomez, V. J. Wacher, S. J. Tomlanovich, M. F. Hebert, and L. Z. Benet. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin. Pharmacol. Ther. 58:15-19 (1995).
L. C. Floren, I. Bekersky, L. Z. Benet, Q. Mekki, D. Dressler, J. W. Lee, J. P. Roberts, and M. F. Hebert. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin. Pharmacol. Ther. 62:41-49 (1997).
M. F. Fromm, D. Busse, H. K. Kroemer, and M. Eichelbaum. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology 24:796-80 (1996).
K. E. Thummel, D. O'Shea, M. F. Paine, D. D. Shen, K. L. Kunze, J. D. Perkins, and G. R. Wilkinson. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin. Pharmacol. Ther. 59:491502 (1996).
H. L. Bonkovsky, H. P. Hauri, U. Marti, R. Gasser, and U. A. Meyer. Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology 88: 458-467 (1985).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265275 (1951).
X. Ding and M. J. Coon. Steroid metabolism by rabbit olfactory-specific P450 2G1. Arch. Biochem. Biophys. 315:454-459 (1994).
T. Kamataki, M. Kitada, H. Shigematsu, and H. Kitagawa. The involvement of cytochrome P-448 and P-450 in NADH-dependent O-demethylation of p-nitroanisole in rat liver microsomes. Jpn. J. Pharmacol. 29:191-201 (1979).
G. F. Rush, J. F. Newton, and J. B. Hook. Sex differences in the excretion of glucuronide conjugates: The role of intrarenal glucuronidation. J. Pharmacol. Exp. Ther. 227:658-662 (1983).
Q. Y. Zhang, J. Wikoff, D. Dunbar, and L. Kaminsky. Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metab. Dispos. 24:322-328 (1996).
T. Koudriakova, E. Iatsimirskaia, S. Tulebaev, D. Spetie, I. Utkin, D. Mullet, T. Thompson, P. Vouros, and N. Gerber. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats. J. Pharmacol. Exp. Ther. 279:1300-1309 (1996).
M. Paolini, J. Barillari, M. Broccoli, L. Pozzetti, P. Perocco, and G. Cantelli-Forti. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolizing enzymes. Cancer Lett. 145:35-42 (1999).
M. J. Fasco, J. B. Silkworth, D. A. Dunbar, and L. S. Kaminsky. Rat small intestinal cytochromes P450 probed by warfarin metabolism. Mol. Pharmacol. 43:226-233 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mohri, K., Uesawa, Y. Enzymatic Activities in the Microsomes Prepared from Rat Small Intestinal Epithelial Cells by Differential Procedures. Pharm Res 18, 1232–1236 (2001). https://doi.org/10.1023/A:1010951732288
Issue Date:
DOI: https://doi.org/10.1023/A:1010951732288